Company Filing History:
1 out of 7 
1 out of 45 
Years Active: 2015-2021
Title: Innovator Spotlight: Rita Elena Serda
Introduction
Rita Elena Serda, based in Pearland, Texas, is a notable inventor with significant contributions to the field of cancer immunotherapy. With two patents to her name, her work focuses on advanced methodologies that enhance the treatment of cancer through innovative compositions and formulations.
Latest Patents
Rita's latest inventions include:
1. **Cationic Liposomes for Cancer Immunotherapy** - This patent discloses positively charged, cytotoxic nanoparticle compositions that incorporate immune modulators such as the toll-like receptor (TLR)-4 ligand, monophosphoryl lipid (MPL)-A, and Interleukin (IL)-12. These compositions demonstrate improved uptake by mammalian cancer cells, leading to increased cancer cell death and enhanced release of cancer antigens when injected directly into tumor populations. These cationic liposomes mark a significant advancement in cancer immunotherapeutics.
2. **Mesoporous Silicon Particles for the Presentation of Tumor Antigens and Adjuvant for Anti-Cancer Immunity** - This patent describes mesoporous silicon multi-stage vehicles that include liposomal-based second-stage particles. The pharmaceutical compositions and formulations provided within this patent are designed for various diagnostic and therapeutic uses, particularly in treating mammalian cancers, including those affecting the human breast.
Career Highlights
Rita has accumulated valuable experience working at prominent research institutions, including The Methodist Hospital Research Institute and The Methodist Hospital. Her tenure at these organizations has allowed her to advance her research and contribute to groundbreaking innovations in cancer treatment.
Collaborations
Throughout her career, Rita has collaborated with talented professionals, including Ismail Mustafa Meraz and Jianhua Gu. These partnerships have enriched her research endeavors and facilitated the development of her innovative patent applications.
Conclusion
Rita Elena Serda stands out as a pioneering inventor in the domain of cancer immunotherapy. Her patented inventions exemplify the potential for innovation in medical science and represent important steps toward improving cancer treatment and patient outcomes. With her dedication to advancing research and collaboration with fellow innovators, Rita continues to contribute to the fight against cancer.